webinar register page

Webinar banner
All you need to know about PROOF-HD
Dr. Michael Hayden, CEO of Prilenia, along with Drs. Andy Feigin and Sandra Kostyk, will provide an overview and insights into the progress of PROOF-HD, a global, Phase 3 study evaluating pridopidine for the treatment of Huntington’s disease. Attendees will also have the opportunity to ask questions about Prilenia, pridopidine and PROOF-HD.

Sep 7, 2022 12:00 PM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Mynelly Perez- HDSA.